China To Restrict Baby Formula Sales To Pharmacies Only By 2015
This article was originally published in PharmAsia News
Beginning in October in China, baby formulae are to be sold only in pharmacies and other stores that meet qualifications to sell medicines under a plan to be phased in over the next two years.
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.